Literature DB >> 7672675

Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting.

H X Xia1, H J Windle, D G Marshall, C J Smyth, C T Keane, C A O'Morain.   

Abstract

The aim of this study was to find out if reinfection or recrudescence accounted for the recurrence of Helicobacter pylori infections after apparent eradication of the bacterium. Three hundred and twenty patients were treated with colloidal bismuth subcitrate (120 mg four times daily for four weeks), metronidazole and tetracycline (400 mg and 500 mg, respectively, thrice daily for the first week). H pylori was eradicated four weeks after the end of treatment as assessed by the rapid urease test, histological examination, Gram staining, and culture. However, the infection recurred in 29 (9.1%) of the patients one year after apparent eradication. Pre and posteradication isolates from five patients were available. DNA was extracted and used for restriction endonuclease analysis with Hind III and Hae III, and for polymerase chain reaction (PCR) based randomly amplified polymorphic DNA fingerprinting with a combination of two 10 nucleotide primers. Sodium dodecyl sulphate polyacrylamide gel electrophoretic analysis was performed also. Randomly amplified polymorphic DNA fingerprinting was unique in that it yielded highly discriminatory fingerprints, which showed that the pretreatment and recurrent isolates obtained from each of the five patients were indistinguishable from one another. This shows that recurrence of H pylori infection is probably caused by recrudescence and that the discriminatory power of randomly amplified polymorphic DNA fingerprinting is a practicable and discriminatory typing scheme for H pylori.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672675      PMCID: PMC1382763          DOI: 10.1136/gut.37.1.30

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Helicobacter pylori and duodenal ulcer recurrence.

Authors:  S Patchett; S Beattie; E Leen; C Keane; C O'Morain
Journal:  Am J Gastroenterol       Date:  1992-01       Impact factor: 10.864

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

5.  Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis.

Authors:  W Langenberg; E A Rauws; A Widjojokusumo; G N Tytgat; H C Zanen
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Fingerprinting genomes using PCR with arbitrary primers.

Authors:  J Welsh; M McClelland
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

7.  Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile.

Authors:  A E Simor; B Shames; B Drumm; P Sherman; D E Low; J L Penner
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Molecular techniques for studying the epidemiology of infection by Helicobacter pylori.

Authors:  M Costas; R J Owen; J Bickley; D R Morgan
Journal:  Scand J Gastroenterol Suppl       Date:  1991

9.  Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation.

Authors:  S I Majewski; C S Goodwin
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

10.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

View more
  10 in total

Review 1.  Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.

Authors:  H X Xia; N J Talley; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

2.  Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis.

Authors:  C Burucoa; V Lhomme; J L Fauchere
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  Serum IgG response to differentiated antigens of Helicobacter pylori.

Authors:  Jie-Song Hua; Mar Mar Khin; Peng-Yuan Zheng; Khay-Guan Yeoh; Han-Chong Ng; Ho Bow
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 4.  A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy.

Authors:  U Peitz; A Hackelsberger; P Malfertheiner
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 5.  Helicobacter pylori persistence in children: distinguishing inadequate treatment, resistant organisms, and reinfection.

Authors:  Diana A Moya; Karen D Crissinger
Journal:  Curr Gastroenterol Rep       Date:  2012-06

6.  Identification of H. pylori in saliva by a nested PCR assay derived from a newly cloned DNA probe.

Authors:  C Jiang; C Li; T Ha; D A Ferguson; D S Chi; J J Laffan; E Thomas
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

7.  Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness.

Authors:  Martin Walker; Sabine Specht; Thomas S Churcher; Achim Hoerauf; Mark J Taylor; María-Gloria Basáñez
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079

8.  Inference from the analysis of genetic structure of Helicobacter pylori strains isolates from two paediatric patients with recurrent infection.

Authors:  Sandra Mendoza-Elizalde; Ana Caren Cortés-Márquez; Gerardo Zuñiga; René Cerritos; Pedro Valencia-Mayoral; Alejandra Consuelo Sánchez; Hector Olivares-Clavijo; Norma Velázquez-Guadarrama
Journal:  BMC Microbiol       Date:  2019-08-08       Impact factor: 3.605

9.  Evaluating the immune responses of mice to subcutaneous immunization with Helicobacter pylori urease B subunit.

Authors:  Peng Sun; Jia-Qi Wang; Yu-Tao Zhang; Sheng-Guo Zhao
Journal:  J Anim Sci Biotechnol       Date:  2014-02-22

10.  Helicobacter pylori is not eradicated after triple therapy: a nested PCR based study.

Authors:  Saurabh Kumar Patel; Girish Narayan Mishra; Chandra Bhan Pratap; Ashok Kumar Jain; Gopal Nath
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.